Background: PET scans using FDG and somatostatin receptor imaging agents have both
been used to study neuroendocrine tumours. Most reports have documented the sensitivity …

Purpose The aim of this study was to systematically review the literature to assess the role of
68 Ga PET imaging in neuroendocrine tumors (NETs). Materials and Methods The literature …

In 2016, the third version of guidelines for the diagnosis and treatment of neuroendocrine
tumors (NETs) has been published by the European Neuroendocrine Tumor Society …

Neuroendocrine tumors (NETs) are rare group of neoplasms arising from nervous and
endocrine systems. Somatostatin analogue imaging is a functional imaging modality of …

Opinion statement Neuroendocrine tumors (NETs) are relatively rare, with 12,000–15,000
new cases diagnosed annually in the USA. Although NETs are a diverse group of …

Somatostatin receptor imaging with 68Ga-DOTATATE PET/CT (DOTATATE) is increasingly
used for managing patients with neuroendocrine tumors. The objective of this study was to …

Neuroendocrine tumors (NET) are often metastatic at the time of diagnosis. Metastatic well-
differentiated (G1/G2) NET may display a wide range of behaviors, ranging from indolent to …

Somatostatin receptor imaging is a valuable tool in the diagnosis, follow-up, and treatment
planning of neuroendocrine tumor (NET). PET-based tracers using 68Ga as the radioisotope …

In patients with neuroendocrine tumours (NETs), a combination of morphological imaging
and nuclear medicine techniques is mandatory for primary tumour visualization, staging and …

Neuroendocrine tumors (NETs) are tumors originated from neuroendocrine cells in the body.
The localization and the detection of the extent of NETs are important for diagnosis and …